Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 19, Pages 13054-13065
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-03-26
DOI
10.1074/jbc.m114.558924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Mycoplasma hominis infection with prostate cancer
- (2015) Yulia A. Barykova et al. Oncotarget
- Mycoplasma PneumoniaeThymidine Phosphorylase
- (2014) Liya Wang et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase
- (2014) Moran Amit et al. OncoImmunology
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
- (2013) N Weizman et al. ONCOGENE
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Bacteria and tumours: causative agents or opportunistic inhabitants?
- (2013) Joanne Cummins et al. Infectious Agents and Cancer
- Characterization of pyrimidine nucleoside phosphorylase ofMycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues
- (2012) Johan Vande Voorde et al. BIOCHEMICAL JOURNAL
- Can mycoplasma contribute to formation of prostate cancer?
- (2012) Sakip M. Erturhan et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Inhibition of Mycobacterial Infection by the Tumor Suppressor PTEN
- (2012) Guochang Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2012) Takayuki Yoshino et al. LANCET ONCOLOGY
- Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
- (2011) Cydney Urbanek et al. BMC CANCER
- Bacterial and fungal microflora in surgically removed lung cancer samples
- (2011) Panagiotis Apostolou et al. Journal of Cardiothoracic Surgery
- Mycoplasma hyorhinisinfection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells
- (2010) Hua Yang et al. BMC GASTROENTEROLOGY
- Influence of Cytidine Deaminase on Antitumor Activity of 2'-Deoxycytidine Analogs In Vitro and In Vivo
- (2010) T. Yoshida et al. DRUG METABOLISM AND DISPOSITION
- Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer
- (2009) William B. Parker CHEMICAL REVIEWS
- Improvement of purine and pyrimidine antimetabolite-based anticancer treatment by selective suppression of mycoplasma-encoded catabolic enzymes
- (2009) Sandra Liekens et al. LANCET ONCOLOGY
- The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy
- (2008) Annelies Bronckaers et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started